Nuclear factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function

Retrovirology

Volumn 3, Issue , 2006, Pages

  Urcuqui Inchima, Silvio ^a   Castaño, Maria Eugenia ^a   Hernandez Verdun, Danièle ^b   St Laurent III, Georges ^c   Kumar, Ajit ^c  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b INSTITUT JACQUES MONOD   (France)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN ENHANCER BINDING FACTOR 3; LEPTOMYCIN B; REV PROTEIN; RNA BINDING PROTEIN; VIRUS RNA;

ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INHIBITION KINETICS; LIFE CYCLE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENE PRODUCTS, REV; GENES, REPORTER; HIV-1; HUMANS; NUCLEAR FACTOR 90 PROTEINS; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA, VIRAL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33947372128     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-83     Document Type: Article

References (44)

1. Cochrane AW, McNally MT, Mouland AJ: The Retrovirus RNA Trafficking granule: From birth to maturity. Retrovirology 2006. 3:18. (17 March 2006)
2. Kjerns J, Askjaer P: Rev protein and its cellular partners. Adv Pharmacol 2000, 48:251-298.
3. Fornerod M, Ohno M, Yoshida M, Mattaj IW: CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997, 90:1051-1060.
4. Pollard VW, Malim MH: The HIV-1 Rev protein. Annu Rev Microbiol 1998, 52:491-532.
5. Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M, Nishida E: CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 1997, 390:308-311.
6. Neville M, Stutz F, Lee L, Davis LI, Rosbash M: The importin-beta family member Crm1 p bridges the interaction between Rev and the nuclear pore complex during nuclear export, Curr Biol 1997. 7:767-775.
7. Askjaer P, Jensen TH, Nilsson J, Englmeier L, Kjems J: The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP. J Biol Chem 1998, 273:33414-33422.
8. Gorlich D, Kutay U: Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol 1999, 15:607-660,
9. Mattaj IW, Englmeier L:TNucleocytoplasmic transport: the soluble phase. Annu Rev Biochem 1998, 67:265-306.
10. Nakeilny S, Dreyfuss G: Transport of proteins and RNAs in and out of the nucleus. Cell 1999, 99:677-690.
11. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT: Requirement a DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004, 119:381-392.
12. Dayton AI: Within you, without you: HIV-1 Rev and RNA export. Retrovirology 2004, 1:35-39.
13. Marques SM, Veyrune JL, Shukla RR, Kumar A: Restriction of human immunodeficiency virus type 1 Rev function in murine A9 cells involves the Rev C-terminal domain. J Virol 2003, 77:3084-3090,
14. Duchange N, Pidoux J, Camus E, Sauvaget D: Alternative splicing in the human interleukin enhancer binding factor 3 (ILF3) gene. Gene 2000, 261:345-353.
15. Saunders LR, Perkins DJ, Belachandran S, Michaels R, Ford R, Mayeda A, Barber GN: Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase PKR. J Biol Chem 2001, 276:32300-32312.
16. Kao PN, Chen L, Brock G, Ng J, Kenny J, Smith AJ, Corthesy B: Cloning and expression of cyclosporin A- and FK506-senative nuclear factor of activated T-cells: NF45 and NF90. J Biol Chem 1994, 269:20691-20699.
17. Langland JO, Kao PN, Jacobs BL: Nuclear factor of activated T-cells: A double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKA. Biochemistry 1999, 38:6361-6368.
18. Liao HJ, Kobayashi R, Machews MB: Activities of adenovirus virus-associated RNAs: Purification and characterization a RNA binding proteins. Proc Natl Acad Sci USA 1998, 95:8514-8519.
19. Shin HJ, Kim SS, Cho YH, Lee SG, Rho HM: Host cell proteins binding to the encapsidation signal epsilon in hepatitis B virus RNA. Arch Virol 2002, 147;471-491.
20. Isken O, Grassmann CW, Sarisky RT, Kann M, Zhang S, Grosse F, Kao PN, Behrens SE: Members of the NF90/NFAR protein group are involved In the life cycle of a positive-trand RNA virus. Embo J 2003, 22:5655-5665.
21. Meagher MJ, Schumacher JM, Lee K, Holdcraft RW, Edelhoff S, Discache C, Braun RE: Identification of ZFR, an ancient and highly conserved murine chromosome-associated zinc finger protein. Gene 1999, 228:197-211.
22. Krasnoselskaya-Riz, I, Spruill A, Chen YW, Schuster D, Teslovich T. Baker C, Kumar A, Stephan DA: Nuclear factor 90 mediates activation of the cellular antiviral expression cascade. AIDS Res Hum Retroviruses 2002, 18:591-604.
23. Parrott AM, Walsh MR, Reichman TW, Machews MB: RNA binding and phosphorylation determine the intracellular distribution of nuclear factors 90 and 110. J Mol Biol 2005, 348:281-293.
24. Shim J, Lim HR. Yates J, Karin M: Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol Cell 2002, 10:1331-1344.
25. Larcher JC, Gasmi L, Viranaicken W, Edde B, Bernard P, Girzburg I, Denoulet P: II13 and NF90 associate with the axonal targeting element of Tau mRNA. Faseb J 2004, 1B:1761-1763.
26. Parker LM, Fierro-Monti I, Mathews MB: Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase. J Biol Chem 2001, 276:32522-32530.
27. Reichaman TW, Muniz LC, Mathews MB: The RNA binding protein nuclear factor 90 functions as both a positive and negative regulator of gene expression in mammalian cells. Mol Cell Biol 2002, 22:343-356.
28. Musacchio A: How SH3 domains recognize proline. Adv Protein Chem 2002, 61:211-268.
29. Zarrinpar A, Bhattacharyya RP, Lim WA: The structure and function of proline recogntion domains. Sci STKE 2003, 2003(179):RE8.
30. Cesareni G, Panni S, Nardelli G, Castagnoli L: Can we infer peptide recognition specificity mediated by SH3 domains? FEBS Lett 2002, 513:30-44.
31. Agrawal V, Kishan KV: Promiscuous binding nature or SH3 domains to their target proteins. Protein Pept 2002, 9:185-193.
32. Coolidge CJ, Parton JG: A new double-stranded RNA-binding protein that interacts witin PKR. Nucleic Acids Res 2000, 28:1407-1417.
33. Patel KC, Vestal DJ, Xu Z, Bandyopadhyay S, Goo W, Erme SM, Williams BR, Sen GC: DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase PKR, J Biol Chem 274:20432-20437.
34. Cullen BR: NucPear RNA export: pathways. Mol Cell Biol 2000, 20;4181-4187.
35. Cullen BR: Nuclear RNA export. J Cell Sci 2003, 116:587-597.
36. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, Hovanessian AG: Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990. 62:379-390.
37. Ryman KD, White LJ, John RE, Klimstra WB: Effect of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenetic. Virol Immunol 2002, 15:53-76.
38. Meyer BE, Meinkoth JL, Malim MH: Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: Identification of a family of transferable nuclear export signals. J Virol 1996, 70:2350-2359.
39. Farjot G. Sergeant A, Milcaelian I: A new nucleoporin-like protein interacts with both HIV-1 Rev nuclear export signal and CRM-1. J Biol Chem 1999, 274:1730
40. Smulevitch S, Bear J, Alicea C, Rosati M, Jalah R, Zolotukhin AS, von Gegerfelt A, Michalowski D, Moroni C, Pavlakis GN, Felber BK: RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependant HIV and SIV mRNAs. Retrovirology 2006, 3:6-15.
41. Malim MH, Bohnlein S, Hauber J, Cullen BR: Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell 1989, 58:205-214.
42. Kudo N, Wolff B, Sekimoto T, Schreiner EP, Yoneda Y, Yanagida M, Horinouchi S, Yoshida M: Leptomycin B inhibition a signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res 1998, 242:540-547.
43. Soros VB, Carvajal HV, Richard S, Cochrane AW: Inhibition of human immunodeficiency virus type 1 Rev function by a dominant-negative mutant of Sam68 through sequestration of unspliced RNA at perinuclear bundles. J Virol 2001, 75:8203-8215.
44. Orsini MJ, Thakur AN, Andrews WW, Hammarskjold ML, Rekosh D: Expression and purification of the HIV type 1 Rev protein produced in Escherichia coli and its use in the generation of monoclonal antobodies. AIDS Res Hum Retroviruses 1995, 11:945-953.